Cargando…

A Novel Secondary Neoplasm Following Allogeneic Hematopoietic Stem Cell Transplant: Mixed Donor-Recipient Primitive Mesenchymal Proliferation of the Liver

Post-hematopoietic stem cell transplant secondary solid neoplasms are uncommon and usually host-derived. We describe a 6-year-old female who developed a mixed donor-recipient origin mesenchymal stromal tumor-like lesion in the liver following an unrelated hematopoietic stem cell transplant complicat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Earl, Brian, Yang, Zi Fan, Rao, Harini, Cheng, Grace, Wall, Donna, Ngan, Bo-Yee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278562/ https://www.ncbi.nlm.nih.gov/pubmed/33729851 http://dx.doi.org/10.1177/10935266211001656

Ejemplares similares

Donor–Recipient Story in Allogeneic Hematopoietic Stem Cell Transplantation
por: Kum, Elena, et al.
Publicado: (2021)

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Different Donors in Recipients With Mucopolysaccharidosis
por: Qu, Yuhua, et al.
Publicado: (2022)

Ageing-resembling phenotype of long-term allogeneic hematopoietic cells recipients compared to their donors
por: Czarnogórski, Michał Cezary, et al.
Publicado: (2022)

PB2203: AGEING OF LONG-TERM ALLOGENEIC HEMATOPOIETIC CELLS RECIPIENTS COMPARED TO THEIR DONORS
por: Czarnogórski, M., et al.
Publicado: (2022)

Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors
por: Tamaki, Masaharu, et al.
Publicado: (2022)

Paired Donor and Recipient Immunophenotyping in Allogeneic Hematopoietic Stem Cell Transplantation: A Cellular Network Approach
por: Wittenbecher, Friedrich, et al.
Publicado: (2022)

Donor Bone Marrow-Derived T Cells Inhibit GVHD Induced by Donor Lymphocyte Infusion in Established Mixed Allogeneic Hematopoietic Chimeras
por: Wang, Hui, et al.
Publicado: (2012)

Cutaneous Legionella infections in allogeneic hematopoietic cell transplantation recipients
por: Vaidya, Toral, et al.
Publicado: (2020)

Allogeneic hematopoietic cell transplantation in adult patients with myelodysplastic/myeloproliferative neoplasms
por: Lim, Sung-Nam, et al.
Publicado: (2013)

Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children
por: Wetzel, Laura, et al.
Publicado: (2021)

Toxoplasma Encephalitis in an Allogeneic Hematopoietic Stem Cell Transplant Recipient in Korea
por: Park, Soo-Kyung, et al.
Publicado: (2012)

Assessment of oral health condition in recipients of allogeneic hematopoietic cell transplantation
por: Reis, Thiago de Carvalho, et al.
Publicado: (2022)

MHC Class I Expression by Donor Hematopoietic Stem Cells Is Required to Prevent NK Cell Attack in Allogeneic, but Not Syngeneic Recipient Mice
por: Hirata, Yuichi, et al.
Publicado: (2015)

Impact of donor and recipient Epstein-Barr Virus serostatus on outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis
por: Kołodziejczak, Michalina, et al.
Publicado: (2021)

Predicting Successful Hematopoietic Stem Cell Collection in Healthy Allogeneic Donors
por: Kayser, Sabine, et al.
Publicado: (2023)

Donor Cell Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation
por: Khattab, Ahmed, et al.
Publicado: (2023)

Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation
por: Lin, Ren, et al.
Publicado: (2013)

Acinetobacter baumannii Septicemia in a Recipient of an Allogeneic Hematopoietic Stem Cell Transplantation
por: Al-Anazi, Khalid Ahmed, et al.
Publicado: (2012)

Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients
por: Yew, P Y, et al.
Publicado: (2015)

Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Stern, Lauren, et al.
Publicado: (2019)

Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation
por: DeFilipp, Zachariah, et al.
Publicado: (2019)

Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients
por: Lahtinen, Atte K., et al.
Publicado: (2022)

Nutritional modulation of the gut microbiome in allogeneic hematopoietic stem cell transplantation recipients
por: Muratore, Edoardo, et al.
Publicado: (2022)

Allogeneic Hematopoietic Cell Transplantation for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
por: Bashir, Qaiser, et al.
Publicado: (2022)

Long-Term Mixed Chimerism After Ex Vivo/In Vivo T Cell-Depleted Allogeneic Hematopoietic Cell Transplantation in Patients With Myeloid Neoplasms
por: Ruhnke, Leo, et al.
Publicado: (2021)

Type I interferon signaling before hematopoietic stem cell transplantation lowers donor T cell activation via reduced allogenicity of recipient cells
por: Fischer, Julius C., et al.
Publicado: (2019)

Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation
por: Morin-Zorman, Sarah, et al.
Publicado: (2016)

The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety
por: Parmar, Gaganvir, et al.
Publicado: (2023)

WU and KI Polyomaviruses in Respiratory Samples from Allogeneic Hematopoietic Cell Transplant Recipients
por: Kuypers, Jane, et al.
Publicado: (2012)

1561. Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant
por: Artau, Annette, et al.
Publicado: (2018)

Optimal Treatment Duration of Pseudomonas aeruginosa Infections in Allogeneic Hematopoietic Cell Transplant Recipients
por: Olearo, Flaminia, et al.
Publicado: (2020)

Mycophenolate mofetil increases the risk of diarrhea in allogeneic hematopoietic stem cell transplantation recipients
por: Lin, Liangmo, et al.
Publicado: (2023)

Is It Better to Mobilize Hematopoietic Stem Cells With Pegfilgrastim in Healthy Donors During Allogeneic Hematopoietic Stem Cell Transplantation?
por: Li, Jiali, et al.
Publicado: (2020)

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis
por: Murthy, Hemant S., et al.
Publicado: (2023)

CXCR4 is required for the quiescence of primitive hematopoietic cells
por: Nie, Yuchun, et al.
Publicado: (2008)

Flotillins Are Involved in the Polarization of Primitive and Mature Hematopoietic Cells
por: Rajendran, Lawrence, et al.
Publicado: (2009)

Current practices in the management of adenovirus infection in allogeneic hematopoietic stem cell transplant recipients in Europe: The AdVance study
por: González‐Vicent, Marta, et al.
Publicado: (2019)

Brucella bacteremia in a recipient of an allogeneic hematopoietic stem cell transplant: a case report
por: Al-Anazi, Khalid A, et al.
Publicado: (2009)

1548. Risk of Severe Herpes Zoster (HZ) in Allogeneic Hematopoietic-Cell Transplantation (HCT) Recipients
por: Baumrin, Emily, et al.
Publicado: (2018)

Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia
por: Damlaj, Moussab, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_140bcn01nea8enj5sbrmuu7ce3